A socially oriented non-financial development institution and a major organizer of international conventions, congress, exhibitions, business, social and sporting, public, and cultural events.

The Roscongress Foundation is a socially oriented non-financial development institution and a major organizer of international conventions; exhibitions; and business, public, sporting, and cultural events. It was established in pursuance of a decision by the President of the Russian Federation.

The Foundation was established in 2007 with the aim of facilitating the development of Russia’s economic potential, promoting its national interests, and strengthening the country’s image. One of the roles of the Foundation is to comprehensively evaluate, analyse, and cover issues on the Russian and global economic agendas. It also offers administrative services, provides promotional support for business projects and attracting investment, and helps foster social entrepreneurship and charitable initiatives.

Each year, the Foundation’s events draw participants from 208 countries and territories, with more than 15,000 media representatives working on-site at Roscongress’ various venues. The Foundation benefits from analytical and professional expertise provided by 5000 people working in Russia and abroad. In addition, it works in close cooperation with 160 economic partners; industrialists’ and entrepreneurs’ unions; and financial, trade, and business associations from 75 countries worldwide.

The Roscongress Foundation has Telegram channels in Russian (t.me/Roscongress), English (t.me/RoscongressDirect), and Spanish (t.me/RoscongressEsp). Official website and Information and Analytical System of the Roscongress Foundation: roscongress.org.

RC personal account
Восстановление пароля
Введите адрес электронной почты или телефон, указанные при регистрации. Вам будет отправлена инструкция по восстановлению пароля.
Некорректный формат электронной почты или телефона
Immunization as an Investment Attraction Point: How Will the Pandemic Change the Vaccine Development Market as a Whole?
2 June 2021
12:15—13:45

The pandemic has tested the immunization industry worldwide, and given it a new impetus. It has given rise to a trend of making next-generation vaccines which are safe, simple to produce, and potentially more universal. Today, enormous investment opportunities are helping to build new markets. These could help usher in a secure future — one in which innovative technologies are used to prevent new epidemics, new vaccines are employed in other areas of immunology, and effective efforts are made to combat new strains, serious infectious diseases, and a whole range of tropical diseases. According to analysts from Morgan Stanley and Credit Suisse, the future coronavirus vaccine market may be worth over USD 10 billion a year. It is too early to forecast income from new vaccines, or to assess the impact the pandemic had on the vaccine market as a whole. However, regardless of whether the pandemic will impact only the current state of the vaccine market or will drive global changes in the future, COVID-19 provided the stimulus for opening new horizons in research and development. How will the pandemic impact the capacity of the global vaccine market? Will COVID-19 become a driver of global change on the market, and what criteria and risks may impact how attractive the vaccine development market will appear to investors in the future? Will projects related to virus research, the development of new platforms, and infectious disease prevention be more heavily financed? How might therapeutic vaccines prevent the spread of infection, and what is the risk of antimicrobial resistance? What innovative developments and severe disease-prevention technologies will offer the greatest promise for investment? Will pharma and biotech industries come to be viewed as more stable for investment?


Date
02.06.2021
Forum
SPIEF
Started at
12:15—13:45
Conference hall
Pavilion G, conference hall G6
Analytics on the topic